BYDUREON (Amylin Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the BYDUREON drug offered from Amylin Pharmaceuticals, LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Amylin Pharmaceuticals, LLC |
NON-PROPRIETARY NAME: | exenatide |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-01-27 |
END MARKETING DATE: | 2018-01-31 |
BYDUREON HUMAN PRESCRIPTION DRUG Details:
Item Description | BYDUREON from Amylin Pharmaceuticals, LLC |
LABELER NAME: | Amylin Pharmaceuticals, LLC |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2012-01-27 |
END MARKETING DATE: | 2018-01-31 |
PRODUCT ID: | 66780-219_11087370-0f16-49f4-a4c5-57296ae1bb52 |
PRODUCT NDC: | 66780-219 |
APPLICATION NUMBER: | NDA022200 |